Privat · Företag · Aksjeselskap

Sarsia Fond Iii AS

927 467 798 ↗Other investment companies, except captive companies · NACE 64.312Bergen

AktivRegistrerad 2021Liknande företag →

Status

● Aktiv

Grundat

2021

Rörelseresultat

kr -9.98M

Slutinvesteringar

4 företag

↳ Brreg · companies

Portfölj · upplöst till slutinvesteringar

Visa platt lista

Ägande följt genom varje holdingbolagsnivå — du landar på det operativa bolaget, inte skalet. Effektiv andel = produkt längs kedjan.

FöretagAndelOmsättningResultatAnstSenaste händelse

ENUA AS

21.4%kr 4.45Mkr -34.5M10

HÁ BIOTECH AS

20%—kr -2.66M—

OFFSHORE SENSING AS

8.3%kr 9.79Mkr -1.41M6

OSMARE AS

20.0%kr 0kr -1.32M5

Aksjonærregisteret-kanter · portfolio_edges · senaste cap table

■ slutinvestering — ett operativt bolag● genomgående holdingbolageffektiv andel = produkt längs kedjan

Portföljtidslinje4 företag

HÁ BIOTECH AS — address_change: postal_post_placeFLORØRegister · 2026-08-04

HÁ BIOTECH AS — address_change: post_code6900 -> 6913Register · 2026-08-04

HÁ BIOTECH AS — address_change: addressBotnaneset 24 -> Gaddholmvegen 204Register · 2026-08-04

HÁ BIOTECH AS — address_change: postal_addressPostboks 6Register · 2026-08-04

HÁ BIOTECH AS — address_change: postal_post_code6901Register · 2026-08-04

HÁ BIOTECH AS — accounts_filed: last_annual_accounts_year2024 -> 2025Register · 2026-07-31

OSMARE AS — accounts_filed: last_annual_accounts_year2024 -> 2025Register · 2026-07-29

OSMARE AS — employees_change: employees5Register · 2026-07-25

OFFSHORE SENSING AS — accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Register · 2026-07-17

OSMARE AS — field_change: registreringsdatoAntallAnsatteEnhetsregisteret2026-06-13 -> 2026-07-15Register · 2026-07-17

OSMARE AS — field_change: registreringsdatoAntallAnsatteNAVAaregisteret2026-06-10 -> 2026-07-10Register · 2026-07-17

ENUA AS — accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Register · 2026-07-15

OSMARE AS — RemunerationPayroll note shows salaries of 2 382 502 and board remuneration of 240 000 for 2025. — Lonn Styrehonorar 2 382 502 240 000 729 557Årsredovisning · 2025-12-31

HÁ BIOTECH AS — Deferred taxA tax loss carryforward of kr 1 173 471 has not been recognised as a deferred tax asset in the balance sheet. — underskudd utgjor kr. 1.1...Årsredovisning · 2025-12-31

HÁ BIOTECH AS — OtherA SkatteFUNN R&D tax credit receivable of kr 389 310 is recorded under other short-term receivables. — Til gode skattefunn utgjor kr. 389...Årsredovisning · 2025-12-31

OSMARE AS — Audit opinionThe auditor Tell Norge AS audited the 2025 financial statements and concluded they meet statutory requirements and give a true and fair v...Årsredovisning · 2025-12-31

OSMARE AS — Audit opinionThe auditor notes as an other matter that the prior period accounts were not audited, so comparative figures are unaudited. — Avlagt arsr...Årsredovisning · 2025-12-31

OSMARE AS — Going concernThe company states it was still in a development phase in 2025 but expects further development and commercial operations. — Selskapet var...Årsredovisning · 2025-12-31

OSMARE AS — Staff numbersThe company employed 1.8 man-years during the financial year. — Antall arsverk sysselsatt i regnskapsaret:Årsredovisning · 2025-12-31

OSMARE AS — Capitalised R&DPayroll costs of 2 834 702 were capitalised in connection with the development project in 2025. — Andre relaterte ytelser Aktiverte lonn...Årsredovisning · 2025-12-31

OSMARE AS — Capitalised R&DThe company has an ongoing development project for non-medicinal treatment methods against salmon lice, capitalised at 15 544 528 with no...Årsredovisning · 2025-12-31

OSMARE AS — OtherThe company has received NOK 3 180 000 in public grant funding from Innovasjon Norge for the development project, reclassified in 2025 as...Årsredovisning · 2025-12-31

OSMARE AS — Share capitalShare capital increased from 46 884 to 59 884 with total cash/contribution in kind of 12 999 900 including share premium. — tingsinnskudd...Årsredovisning · 2025-12-31

OSMARE AS — Share capitalEquity at 31.12.2025 was 23 201 353 comprising share capital 59 884, share premium 25 208 016, other paid-in equity -5 870 and uncovered ...Årsredovisning · 2025-12-31

OSMARE AS — Deferred taxA deferred tax asset of 581 504 was recognised at 31.12.2025 based on 22%, mainly from carried-forward losses. — Utsattskattefordel31.12....Årsredovisning · 2025-12-31

OSMARE AS — OtherOf bank deposits, 146 452 relates to withheld employee taxes. — Skyldigskattetrekk -146 452Årsredovisning · 2025-12-31

HÁ BIOTECH AS — Audit opinionThe auditor Cedra Norge AS issued an unmodified opinion that the accounts comply with statutory requirements and give a true and fair vie...Årsredovisning · 2025-12-31

HÁ BIOTECH AS — OwnershipThe company is owned by four shareholders: Tres Biotechnology AS 40%, Havlandet Breed AS 20%, RaneL AS 20% and Sarsia Fond II AS 20%. — T...Årsredovisning · 2025-12-31

HÁ BIOTECH AS — Share capitalShare capital is NOK 1 650 000 divided into 3 300 000 shares of nominal value 0,5. — Aksjer Aksjekapitalen : Antall 3300000 Palydende...Årsredovisning · 2025-12-31

HÁ BIOTECH AS — DividendNo dividend is proposed for 2025 (nil), against 965 657 the previous year; the loss is covered by transfer from equity. — Overfort fra eg...Årsredovisning · 2025-12-31

HÁ BIOTECH AS — Related partyBoard member Bjørn Tore Gjertsen indirectly owns 1 320 000 shares, 40% of the company. — Bjom Tore Gjertsen Styremedlem 1 320 000 40 %...Årsredovisning · 2025-12-31

HÁ BIOTECH AS — Staff numbersThe company reported 0.50 man-years (årsverk) in the financial year in the form notes. — Antall 0.50 arsverk iregnskapsaretÅrsredovisning · 2025-12-31

HÁ BIOTECH AS — Staff numbersAverage number of employees was 1.5 in 2025 against 1.0 in 2024. — Ansatte: Gjennomsnittig antall ansatte 2025 1,5 2024 1,0Årsredovisning · 2025-12-31

HÁ BIOTECH AS — RemunerationPayroll costs consist of salary of 1 293 731, employer's contributions and pension costs, totalling 1 605 261. — Lonn Lonnskostnad: 1 2...Årsredovisning · 2025-12-31

ENUA AS — NORBIT ASA exited (held 11.4 pct)Ägare lämnar · 2024-12-31

HÁ BIOTECH AS — TRES BIOTECHNOLOGY AS acquired 40.0 pctNy ägare · 2024-12-31

OSMARE AS — SARSIA FOND III AS acquired 12.8 pctNy ägare · 2024-12-31

OSMARE AS — COAST INVEST AS acquired 12.8 pctNy ägare · 2024-12-31

HÁ BIOTECH AS — SARSIA FOND III AS acquired 20.0 pctNy ägare · 2024-12-31

ENUA AS — SARSIA FOND III AS acquired 20.5 pctNy ägare · 2023-12-31

Visar de 40 senaste händelserna

Skiwo · company_events